Andrew J. Armanino, Director at Better Therapeutics, Inc. (BTTX), bought 606,060 shares at $0.83 ($503K) on 2023-04-10, disclosed to the SEC on 2023-04-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.83 | 303,030 | $252K | 50.0% |
| 2 | $0.83 | 303,030 | $252K | 50.0% |
| Total | $0.83 avg | 606,060 | $503K | 100% |
| Filing → |
| BTTX | BUY | 2022-06-16 | $21K | — | Filing → |
| BTTX | BUY | 2022-06-10 | $41K | — | Filing → |
| BTTX | BUY | 2022-03-31 | $86K | — | Filing → |